普遍接种乙肝疫苗实施前后出生人群的乙肝表面抗体血清流行率
该研究检测了阿根廷132名2000年后出生儿童和762名18岁以上献血者的乙肝表面抗体,抗体滴度≥10 mIU/mL者分别为56.1%和44.1%。1992年或之前出生的献血者保护率32.2%,显著低于1992年后出生者的75.2%(P<0.0001),不同参与中心间血清保护状态也存在显著差异(P=0.024)。
要点
- 儿童抗-HBs血清保护率为56.1%(74/132),献血者为44.1%(336/762)。
- 1992年后出生献血者保护率75.2%,高于1992年或之前出生者的32.2%(P<0.0001)。
- 不同参与中心间血清保护状态存在显著差异(P=0.024)。
核心结论
- 2000年和2003年实施乙肝疫苗接种后,抗-HBs血清保护率总体上升,11岁接种儿童的应答尤为理想。
- 观察结果提示1992年或之前出生的人群目前最易感,作者建议提高该年龄组的传播风险意识并加强疫苗接种活动。
研究设计与样本
- 研究分析了来自全国五个中心的132名2000年后出生儿童和762名18岁以上献血者的HBsAg和 anti-HBc 阴性血清样本,检测抗-HBs。
主要发现
- 抗-HBs滴度≥10 mIU/mL者:儿童74/132(56.1%),献血者336/762(44.1%)。
- 献血者中位年龄33.9岁(23-43),其中210人(27.6%)出生于1992年后,为11岁疫苗接种的补种人群。
- 1992年或之前出生献血者保护率为32.2%,1992年后出生者为75.2%,差异显著(P<0.0001)。
- 不同参与中心间血清保护状态存在显著差异(P=0.024)。
临床怎么用
- 作者建议提高1992年或之前出生年龄组的传播风险意识,并加强该人群的疫苗接种活动。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Universal vaccination is the most effective strategy to control hepatitis B virus (HBV) infection. In Argentina, vaccination against HBV was incorporated in year 2000 for newborns and in 2003 for 11 years old children. However, there is a paucity of data about protection levels against HBV infection. The aim of this work was to determine the prevalence of seroprotective anti-HBs antibodies (aHBs) in Argentina. Serum samples negative for HBsAg and anti-HBc from 132 children born after year 2000 and 762 blood donors, older than 18 years, from five centers across the country, were analyzed for aHBs. Titers ≥10 mIU/mL were observed in 74/132 children (56.1%) and 336/762 (44.1%) in blood donors. The median age for blood donors was 33.9 (23-43); from them, 210 (27.6%) were born after 1992 and, therefore, were catch-up by vaccine implementation at 11 years old age. Donors born in 1992 or before showed a significantly lower frequency of protection (32.2%) compared to donors born after 1992 (75.2%), p < 0.0001. In addition, significant differences were observed in the status of seroprotection between different participating centers (p = 0.024). Implementation of HBV vaccine in 2000 and 2003 implied an overall increase of the aHBs seroprotective rates, with a particularly adequate response in children vaccinated at 11 years old age. The observed results suggest that population born in 1992 or before is currently the most susceptible. Consequently, it would be advisable to become aware of the risk of transmission in this age group and to stress this population vaccination campaigns.
引用
- Di Lello FA, Blejer J, Alter A, et al. Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination. Vaccine. 2020. PMID: 32061386. doi:10.1016/j.vaccine.2020.02.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。